These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 27470544)

  • 1. Increased MALAT1 expression predicts poor prognosis in esophageal cancer patients.
    Huang C; Yu Z; Yang H; Lin Y
    Biomed Pharmacother; 2016 Oct; 83():8-13. PubMed ID: 27470544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Expression of Long Noncoding RNA MALAT1 Indicates a Poor Prognosis and Promotes Clinical Progression and Metastasis in Bladder Cancer.
    Li C; Cui Y; Liu LF; Ren WB; Li QQ; Zhou X; Li YL; Li Y; Bai XY; Zu XB
    Clin Genitourin Cancer; 2017 Oct; 15(5):570-576. PubMed ID: 28648755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MALAT1 might be a predictive marker of poor prognosis in patients who underwent radical resection of middle thoracic esophageal squamous cell carcinoma.
    Cao X; Zhao R; Chen Q; Zhao Y; Zhang B; Zhang Y; Yu J; Han G; Cao W; Li J; Chen X
    Cancer Biomark; 2015; 15(6):717-23. PubMed ID: 26406400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma.
    Zhang HM; Yang FQ; Chen SJ; Che J; Zheng JH
    Tumour Biol; 2015 Apr; 36(4):2947-55. PubMed ID: 25480417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of long non-coding RNA MALAT1 is correlated with clinical progression and unfavorable prognosis in pancreatic cancer.
    Pang EJ; Yang R; Fu XB; Liu YF
    Tumour Biol; 2015 Apr; 36(4):2403-7. PubMed ID: 25481511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA MALAT1 promotes epithelial-to-mesenchymal transition of esophageal cancer through Ezh2-Notch1 signaling pathway.
    Chen M; Xia Z; Chen C; Hu W; Yuan Y
    Anticancer Drugs; 2018 Sep; 29(8):767-773. PubMed ID: 29916899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 regulates the expression of Gli2 by miR-202 to strengthen gastric cancer progression.
    Zhang Y; Chen Z; Li MJ; Guo HY; Jing NC
    Biomed Pharmacother; 2017 Jan; 85():264-271. PubMed ID: 27887846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA MALAT1 associates with the malignant status and poor prognosis in glioma.
    Ma KX; Wang HJ; Li XR; Li T; Su G; Yang P; Wu JW
    Tumour Biol; 2015 May; 36(5):3355-9. PubMed ID: 25613066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of long non-coding RNA MALAT1 in breast cancer is associated with poor relapse-free survival.
    Wang Z; Katsaros D; Biglia N; Shen Y; Fu Y; Loo LWM; Jia W; Obata Y; Yu H
    Breast Cancer Res Treat; 2018 Sep; 171(2):261-271. PubMed ID: 29845475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Significance of Long Non-coding RNA MALAT1 Expression in Tissue and Serum of Breast Cancer.
    Miao Y; Fan R; Chen L; Qian H
    Ann Clin Lab Sci; 2016 Jul; 46(4):418-24. PubMed ID: 27466303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexmedetomidine inhibits the growth and metastasis of esophageal cancer cells by down-regulation of lncRNA MALAT1.
    Zhang W; Zhang L; Cai XJ; Li D; Cao FJ; Zuo ZG; Song Y; Yu XJ; Liu S
    Kaohsiung J Med Sci; 2022 Jun; 38(6):585-593. PubMed ID: 35199933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-Regulated Expression of SPRY4-IT1 Predicts Poor Prognosis in Colorectal Cancer.
    Tan W; Song ZZ; Xu Q; Qu X; Li Z; Wang Y; Yu Q; Wang S
    Med Sci Monit; 2017 Jan; 23():309-314. PubMed ID: 28099409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA MALAT1 is an independent prognostic factor of osteosarcoma.
    Gao KT; Lian D
    Eur Rev Med Pharmacol Sci; 2016 Sep; 20(17):3561-5. PubMed ID: 27649655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Expression of Long Non-Coding RNA BCAR4 Is Predictive of Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
    Gong J; Zhang H; He L; Wang L; Wang J
    Tohoku J Exp Med; 2017 Jan; 241(1):29-34. PubMed ID: 28077810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High MALAT1 expression predicts a poor prognosis of cervical cancer and promotes cancer cell growth and invasion.
    Yang L; Bai HS; Deng Y; Fan L
    Eur Rev Med Pharmacol Sci; 2015 Sep; 19(17):3187-93. PubMed ID: 26400521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA MALAT1 affects the efficacy of radiotherapy for esophageal squamous cell carcinoma by regulating Cks1 expression.
    Li Z; Zhou Y; Tu B; Bu Y; Liu A; Kong J
    J Oral Pathol Med; 2017 Sep; 46(8):583-590. PubMed ID: 27935117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer.
    Zheng HT; Shi DB; Wang YW; Li XX; Xu Y; Tripathi P; Gu WL; Cai GX; Cai SJ
    Int J Clin Exp Pathol; 2014; 7(6):3174-81. PubMed ID: 25031737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low expression of long non-coding RNA GAS5 is associated with poor prognosis of patients with thyroid cancer.
    Guo LJ; Zhang S; Gao B; Jiang Y; Zhang XH; Tian WG; Hao S; Zhao JJ; Zhang G; Hu CY; Yan J; Luo DL
    Exp Mol Pathol; 2017 Jun; 102(3):500-504. PubMed ID: 28506768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased expression of lncRNA GAS5 predicts a poor prognosis in cervical cancer.
    Cao S; Liu W; Li F; Zhao W; Qin C
    Int J Clin Exp Pathol; 2014; 7(10):6776-83. PubMed ID: 25400758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of long noncoding RNA MALAT1 in various carcinomas: evidence from nine studies.
    Xue Y; Teng YQ; Zhou JD; Rui YJ
    Tumour Biol; 2016 Jan; 37(1):1211-5. PubMed ID: 26282005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.